| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/03/2007 | US7238690 Substituted heterocycle fused gamma-carbolines |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 07/03/2007 | US7238667 Albumin fusion proteins |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238663 Comprising a GLP-1 compound and an acylated basal insulin or a pI shifted basal insulin; can be used to treat diseases such as non-insulin dependent diabetes mellitus and insulin dependent diabetes mellitus, hyperglycemia, obesity |
| 07/03/2007 | US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 07/03/2007 | US7238657 Cartilage/Bone inducing materials for preparation |
| 07/03/2007 | CA2416901C Pharmaceutical compositions comprising a lipase inhibitor and a bile acid sequestrant and their use in the prevention and treatment of obesity |
| 07/03/2007 | CA2416900C The use of a combination of a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant for the prevention and treatment of diseases associated with high plasma cholesterol levels |
| 07/03/2007 | CA2384859C High lipid diet |
| 07/03/2007 | CA2382548C Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 06/28/2007 | WO2007073555A1 Use of 4, 7-dihydrothieno [2, 3-b] pyridine compounds in the treatment of cardiovascular diseases |
| 06/28/2007 | WO2007073187A1 Carbohydrate composition for flat glucose response |
| 06/28/2007 | WO2007073136A1 Pharmaceutical compositions containing derivative substances of thiazolidinediones combined with a biguanide for use in type 2 diabetes mellitus |
| 06/28/2007 | WO2007073134A1 Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight |
| 06/28/2007 | WO2007073133A1 Pharmaceutical compositions containing substances that inhibit the reuptake of noradrenaline, dopamine and serotonin, which are combined with an amino acid for the treatment of obesity and overweight |
| 06/28/2007 | WO2007073117A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072971A1 Agent for improving angiopathy containing sulfated polysaccharide derived from green alga and method for producing the same |
| 06/28/2007 | WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME |
| 06/28/2007 | WO2007072756A1 Mineral absorption enhancer, food and feeding stuff |
| 06/28/2007 | WO2007072083A1 Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione |
| 06/28/2007 | WO2007071966A1 Pyrimido- [4, 5-b] -oxazines for use as dgat inhibitors |
| 06/28/2007 | WO2007071766A2 Phenoxy acetic acids as ppar delta activators |
| 06/28/2007 | WO2007071738A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | WO2007071728A1 Hydantoins with insulinotropic action |
| 06/28/2007 | WO2007071357A2 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid |
| 06/28/2007 | WO2007071334A2 Ethanol-precipitated phaseolus vulgaris extracts, their use and formulations |
| 06/28/2007 | WO2007071038A2 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers |
| 06/28/2007 | WO2007071036A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/28/2007 | WO2007071023A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | WO2007071012A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 06/28/2007 | WO2007070961A1 Mif inhibitors |
| 06/28/2007 | WO2007044085A3 Heteroaryl compounds and their uses as therapeutic agents |
| 06/28/2007 | WO2007009529A3 Calcium-peptide component |
| 06/28/2007 | WO2006134340A3 Oxyntomodulin analogues and their effects on feeding behaviour |
| 06/28/2007 | WO2006120213A3 Novel use of liver x receptor agonists |
| 06/28/2007 | US20070149614 Guanidine and amidine acid derivatives and analogs and methods of using the same |
| 06/28/2007 | US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 06/28/2007 | US20070149587 Valsartan Salts |
| 06/28/2007 | US20070149555 Prophylatic and/or therapeutic agents for chronic musculoskeletal pain |
| 06/28/2007 | US20070149545 Substituted indan derivatives |
| 06/28/2007 | US20070149514 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds |
| 06/28/2007 | US20070149455 Modified and stabilized gdf propeptides and uses thereof |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148317 Functional component-enriched barley malt rootlets and process for producing the same |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | DE102005061655A1 Diazepinone Diazepinones |
| 06/28/2007 | DE102005052442A1 Strukturierte Lipidgemische Structured lipid mixtures |
| 06/28/2007 | CA2673010A1 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers |
| 06/28/2007 | CA2673005A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/28/2007 | CA2634379A1 Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione |
| 06/28/2007 | CA2634258A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 06/28/2007 | CA2634212A1 Mif inhibitors |
| 06/28/2007 | CA2634158A1 Use of 4, 7-dihydrothieno ¬2, 3-b| pyridine compounds in the treatment of cardiovascular diseases |
| 06/28/2007 | CA2633740A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 06/28/2007 | CA2633484A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | CA2632936A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | CA2631390A1 Phenoxy acetic acids as ppar delta activators |
| 06/28/2007 | CA2630704A1 Pharmaceutical composition |
| 06/28/2007 | CA2611737A1 Formulations containing glimepiride and/or its salts |
| 06/27/2007 | EP1801226A2 Arachidonic acid and methods for the production and use thereof |
| 06/27/2007 | EP1801193A1 Process for producing concentrate of unsaturated fatty acid |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
| 06/27/2007 | EP1800685A1 Steroidal saponin pharmaceutical composition, its preparation method and use |
| 06/27/2007 | EP1800674A1 Agent for preventing metabolic syndrome |
| 06/27/2007 | EP1800669A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | EP1799648A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 06/27/2007 | EP1799647A1 Alkil-pyridines as 11-beta inhibitors for diabetes |
| 06/27/2007 | EP1799198A1 Methods and compositions for the treatment of diseases characterized by pathological calcification |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1311264B1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1280784B1 Biologically active 4h-benzo 1,4|oxazin-3-ones |
| 06/27/2007 | EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition |
| 06/27/2007 | EP1107986B1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/27/2007 | CN1989132A Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 06/27/2007 | CN1989129A A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinicarbox amide hemisuccinate salt |
| 06/27/2007 | CN1989123A Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 06/27/2007 | CN1989120A Guanidine derivatives and therapeutic uses thereof |
| 06/27/2007 | CN1989116A Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (P T P 1 B) inhibitors for using as blood-sugar decreasing active ingredients for treating |
| 06/27/2007 | CN1988905A Aryl-pyridine derivatives |
| 06/27/2007 | CN1988902A Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 06/27/2007 | CN1986532A Organic acid salt of N-piperidyl-1-(2,4-dichlorophenyl)-4-methyl-5-(4-chlorophenyl)-pyrazolyl-3-formamide and its preparing method |
| 06/27/2007 | CN1985985A Recipe and preparing process of food therapeutic preparation and functional food |
| 06/27/2007 | CN1985978A Compound preparation for reducing fat deposit in liver and alleviating fatty degeneration of liver cell |
| 06/27/2007 | CN1985943A Extraction process of aloe gel concentrate |
| 06/27/2007 | CN1985925A Extraction, application and medicine composition of franchet groundcherry steride |
| 06/27/2007 | CN1985919A Chinese medicine composition for treating facial stain and other endocrinic gynecopathy |
| 06/27/2007 | CN1985917A Medicine composition for reducing blood sugar, reducing blood fat and controlling diabetes complication |